Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications

Meyoung-Kon Kim, Hyeh Jean Jeong, Chih Hao K. Kao, Zhengsheng Yao, David S. Paik, Jae Eun Pie, Hisataka Kobayashi, Thomas A. Waldmann, Jorge A. Carrasquillo, Chang H. Paik

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This study was undertaken to improve the renal clearance and tumor targeting properties of 99mTc-labeled humanized anti-Tac (HuTac) monoclonal antibody Fab fragments using two chemical approaches: 1) labeling with a renal secretion agent 99mTc-mercaptoacetyltriglycine (MAG3) and 2) lowering its isoelectric point (pI) by acylation. HuTac Fab (3.3 mg/mL) was reacted with a trifluorophenyl ester (TFP) of 99mTc-MAG3 alone or was additionally reacted with TFP-glycolate to reduce the pI. In Balb/c mice, 99mTc-MAG3-Fab (pI > 9.3) rapidly accumulated in the kidneys (177% injected dose [ID]/g at 15 min) and then gradually cleared out of the kidneys. In contrast, the glycolation (pI 4.6∼6.6) drastically reduced the renal uptake (31% ID/g) and also the whole-body retention (82% ID vs 101% for the nonglycolated) at 15 min, indicating that the glycolated 99mTc-MAG3-Fab (pI 4.6∼6.6) was rapidly excreted. The glycolated remained in the blood longer than the nonglycolated (1.2% vs 0.3% ID/g at 360 min), but this effect was less drastic than the effect shown on the renal uptake. In nude mice bearing receptor-positive (ATAC4) tumors, the glycolated 99mTc-MAG3-Fab increased the peak tumor uptake to 14.8% ID/g from 8.3% ID/g for 99mTc-MAG3-Fab, whereas the glycolation resulted in a drastic reduction of the renal uptake at 15 min. We demonstrated that the renal clearance and the tumor targeting of Fab could be optimized by chemical modifications.

Original languageEnglish
Pages (from-to)139-146
Number of pages8
JournalNuclear Medicine and Biology
Volume29
Issue number2
DOIs
Publication statusPublished - 2002 Feb 16
Externally publishedYes

Keywords

  • Tc-MAG3-Antibody Fragments
  • Acylation
  • Rapid Renal Clearance
  • Tumor Targeting

ASJC Scopus subject areas

  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Improved renal clearance and tumor targeting of <sup>99m</sup>Tc-labeled anti-Tac monoclonal antibody Fab by chemical modifications'. Together they form a unique fingerprint.

  • Cite this

    Kim, M-K., Jeong, H. J., Kao, C. H. K., Yao, Z., Paik, D. S., Pie, J. E., Kobayashi, H., Waldmann, T. A., Carrasquillo, J. A., & Paik, C. H. (2002). Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications. Nuclear Medicine and Biology, 29(2), 139-146. https://doi.org/10.1016/S0969-8051(01)00296-7